SCHEMBL18652199

SCHEMBL18652199

CCCN(C)C(=O)c1ccc2ccccc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.56
KCNH2 Q12809 1/20 0.56
PDK2 Q15119 1/20 0.52
HDAC3 O15379 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC2 Q92769 2/20 0.50
TNF P01375 1/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 1/20 0.49
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
ACHE P22303 1/20 0.48
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
PTPN1 P18031 1/20 0.47
NAMPT P43490 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9130521 0.91 PDK2 (0.54) SLC6A4KCNH2PDK2HDAC3HDAC1
SCHEMBL17197988 0.87 CES2 (0.53) SLC6A4KCNH2PDK2HDAC3HDAC1
SCHEMBL18650133 0.79 CES2 (0.49) SLC6A4KCNH2HDAC3HDAC1HDAC2
SCHEMBL7011836 0.79 CES2 (0.61) SLC6A4CES2CES1SMN1; SMN2NPC1
SCHEMBL1006489 0.79 NAMPT (0.54) PDK2HDAC1ALDH1A1ACHEHPGD
SCHEMBL28897045 0.79 HSD17B1 (0.55) PDK2ALDH1A1KDM4EHPGDNAMPT
SCHEMBL14052528 0.78 HPGD (0.64) CES2CES1SMN1; SMN2NPC1ALDH1A1
SCHEMBL3302319 0.78 CES2 (0.59) CES2CES1SMN1; SMN2ALDH1A1ESR1
SCHEMBL22542595 0.77 HDAC3 (0.51) SLC6A4KCNH2HDAC3HDAC1HDAC2
SCHEMBL11250526 0.77 MAOA (0.54) SLC6A4KCNH2HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170081346-A1 MESOSCOPIC MATERIALS COMPRISED OF ORDERED SUPERLATTICES OF MICROPOROUS METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081346-A1 MESOSCOPIC MATERIALS COMPRISED OF ORDERED SUPERLATTICES OF MICROPOROUS METAL-ORGANIC FRAMEWORKS MCM2, YTHDF2, MCM6 SLC6A4 1821/4885KCNH2 3918/4885PDK2 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.